ALPHAGAN P OPHTHALMIC SOLUTION 0.15% w/v

INDICATIONS AND USAGE

ALPHAGAN® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

CONTRAINDICATIONS

ALPHAGAN® P is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy and contraindicated in neonates and infants (children under the age of 2 years).

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% in the affected eye(s) three times daily, approximately 8 hours apart.

If more than one topical ophthalmic drug is to be used, the different drugs should be instilled at least 5 minutes apart.